Skip to content

Foreskin seller posts growth, predicts $100 million in stimulus business

January 29, 2010 - 12:37 pm

Anti-circumcision activists went nuts in the comments on our story last week about local biotech companies who use foreskin fibroblasts (cells derived from the excised neonatal skin) in their health products.

For Carlsbad-based Invitrogen, a subsidiary of Life Technologies, foreskin fibroblasts ($339 for a 500,000-cell vial) are just one of its 50,000 products. Nevertheless, we felt it was important to point out today’s San Diego Union-Tribune story, “Life Tech quarter surprises analysts.”

According to the U-T:

The company, born of the 2008 merger of Carlsbad’s Invitrogen and instrument maker Applied Biosystems, said revenue grew 14 percent to $874.1 million for the consolidated operation. Net income of $48.9 million, or 26 cents a share, compared with a loss in the 2008 fourth quarter, during which the merger took place.

Life Technologies’ fibroblast product is pretty much insignificant when it comes to the revenue boost, which the U-T attributes to the demand for its H1N1 products. Nevertheless, “intactivists” will be irked to learn that federal stimulus money has directed $45 million in business to Life Technologies’ and the company predicts another $100 million in stimulus-related business in 2010.

No comments yet

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: